OSLO, Norway—Bridge Technologies has unveiled a multiservice AV sync comparison feature to the AV Sync function of its VB440 production probe, enabling seamless, glitch-free switching. The new feature ...

Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...

US POINTER, a healthy lifestyle intervention, helped participants improve blood pressure regulation of blood flow to the brain, reduced sleep apnea respiratory events, and increased cognitive ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS). RRMS ...

The U.S. Department of Education said Tuesday it’s developed six agreements to send many of its key functions to other federal agencies. A majority of the Education Department’s funding for K-12 ...

The state cited Care Crossings for more than 100 breaches of state law or rules. Whistleblowers say the business has long had issues. A new state report has cited a Stillwater-area substance abuse ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

If you see multiple processes of the same program running on your Windows 11 PC, there is no need to panic, as this is a normal behavior of all Windows computers. However, if you experience ...

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of ...

WASHINGTON — The Department of Army today announced the launch of the Janus Program, a next-generation nuclear power program that will deliver resilient, secure, and assured energy to support national ...

The abrupt programming decision quickly morphed into a flashpoint for free speech in America under the Trump administration. By John Koblin Brooks Barnes Benjamin Mullin and Michael M. Grynbaum For ...